Literature DB >> 29128323

Who needs antipsychotic maintenance treatment and who does not? Our need to profile and personalize the treatment of first episode psychosis.

Lex Wunderink1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29128323     DOI： 10.1016/j.schres.2017.11.007

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  3 in total

1.  Onset and transition of and recovery from adverse development: Study methodology.

Authors:  Johanna T W Wigman; Gerdina H M Pijnenborg; Richard Bruggeman; Maarten Vos; Anita Wessels; Inez Oosterholt; Maaike Nauta; Renee Stelwagen; Lana Otto; Anniek Wester; Lex Wunderink; Esther Sportel; Nynke Boonstra
Journal:  Early Interv Psychiatry       Date:  2019-11-05       Impact factor: 2.732

2.  One-Year Treatment with Olanzapine Depot in Female Rats: Metabolic Effects.

Authors:  Kari M Ersland; Lene S Myrmel; Even Fjære; Rolf K Berge; Lise Madsen; Vidar M Steen; Silje Skrede
Journal:  Int J Neuropsychopharmacol       Date:  2019-05-01       Impact factor: 5.176

3.  Medication strategies in first episode psychosis patients: A survey among psychiatrists.

Authors:  Martijn J Kikkert; Wim Veling; Lieuwe de Haan; Marieke J H Begemann; Mariken de Koning; Iris E Sommer
Journal:  Early Interv Psychiatry       Date:  2021-03-22       Impact factor: 2.721
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.